OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AGCC$17.5356

Agencia Comercial Spirits Ltd

Food Retail & DistributionVerified

The company maintains a strong liquidity position, with a current ratio of 1.91, indicating that it has sufficient current assets to cover its short-term liabilities. However, the operating cash flow is negative at -$236,840, which may raise concerns about its ability to generate cash from operations. The liquidity risk is assessed as low, suggesting that the company is not currently facing significant liquidity challenges. In terms of profitability, the company's return on equity (ROE) is 41.01%, which is significantly higher than the typical benchmark for the industry, indicating strong returns for shareholders. The return on assets (ROA) is 19.92%, also suggesting efficient use of assets to generate profit. The debt-to-equity ratio is 0.02, indicating a very low level of leverage and a conservative capital structure. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification may expose the company to higher risks if the primary market experiences a downturn. The company's revenue is entirely derived from its core operations in the Food & Drug Retailing sector, with no material contributions from other segments. The company's growth trajectory is not clearly defined, as there are no specific numeric deltas provided for the current or next fiscal year. However, the company's high ROE and ROA suggest that it is currently performing well and may have the potential for continued growth. The company's revenue history indicates a strong performance, with a gross profit of $1,265,300 and an operating income of $1,014,580. The risk assessment indicates that the company has a low risk of dilution, with no immediate filing-based liquidity or dilution flags detected. The company's capital structure is conservative, with a low level of long-term debt ($47,470) and a high level of equity ($1,900,200). The company's valuation multiples, such as the price-to-earnings ratio of 512.59 and the price-to-book ratio of 210.21, suggest that the stock is currently overvalued relative to its earnings and book value. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's financial statements show a strong balance sheet with total assets of $3,912,630 and total liabilities of $2,012,430. The company's net income of $779,280 indicates a healthy profit margin, which is a positive sign for investors.

30-day price · AGCC(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyAgencia Comercial Spirits Ltd
TickerAGCC.O
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Agencia Comercial Spirits Ltd operates in the Food & Drug Retailing sector, primarily engaged in the distribution and retail of food and beverage products.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food Retail & Distribution industry, with a confidence level of 0.92.

The company maintains a strong liquidity position, with a current ratio of 1.91, indicating that it has sufficient current assets to cover its short-term liabilities. However, the operating cash flow is negative at -$236,840, which may raise concerns about its ability to generate cash from operations. The liquidity risk is assessed as low, suggesting that the company is not currently facing significant liquidity challenges. In terms of profitability, the company's return on equity (ROE) is 41.01%, which is significantly higher than the typical benchmark for the industry, indicating strong returns for shareholders. The return on assets (ROA) is 19.92%, also suggesting efficient use of assets to generate profit. The debt-to-equity ratio is 0.02, indicating a very low level of leverage and a conservative capital structure. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification may expose the company to higher risks if the primary market experiences a downturn. The company's revenue is entirely derived from its core operations in the Food & Drug Retailing sector, with no material contributions from other segments. The company's growth trajectory is not clearly defined, as there are no specific numeric deltas provided for the current or next fiscal year. However, the company's high ROE and ROA suggest that it is currently performing well and may have the potential for continued growth. The company's revenue history indicates a strong performance, with a gross profit of $1,265,300 and an operating income of $1,014,580. The risk assessment indicates that the company has a low risk of dilution, with no immediate filing-based liquidity or dilution flags detected. The company's capital structure is conservative, with a low level of long-term debt ($47,470) and a high level of equity ($1,900,200). The company's valuation multiples, such as the price-to-earnings ratio of 512.59 and the price-to-book ratio of 210.21, suggest that the stock is currently overvalued relative to its earnings and book value. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's financial statements show a strong balance sheet with total assets of $3,912,630 and total liabilities of $2,012,430. The company's net income of $779,280 indicates a healthy profit margin, which is a positive sign for investors.
Key takeaways
  • The company has a strong liquidity position with a current ratio of 1.91.
  • The company's return on equity (41.01%) and return on assets (19.92%) are significantly higher than typical industry benchmarks.
  • The company's revenue is concentrated in a single business segment, which may increase its exposure to market risks.
  • The company's valuation multiples suggest that the stock is currently overvalued relative to its earnings and book value.
  • The company has a low risk of dilution and a conservative capital structure with a low level of leverage.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$2.5M
Gross profit$1.3M
Operating income$1.0M
Net income$779.3k
R&D
SG&A
D&A
SBC
Operating cash flow-$236.8k
CapEx
Free cash flow
Total assets$3.9M
Total liabilities$2.0M
Total equity$1.9M
Cash & equivalents$54.8k
Long-term debt$47.5k
Valuation
Market price$17.53
Market cap$399.4M
Enterprise value$399.4M
P/E512.6
Reported non-GAAP P/E
EV/Revenue157.4
EV/Op income393.7
EV/OCF
P/B210.2
P/Tangible book210.2
Tangible book$1.9M
Net cash$7.3k
Current ratio1.9
Debt/Equity0.0
ROA19.9%
ROE41.0%
Cash conversion-30.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricAGCCActivity
Op margin40.0%3.1% medp25 1.2% · p75 6.8%top quartile
Net margin30.7%2.0% medp25 0.7% · p75 4.1%top quartile
Gross margin49.9%26.1% medp25 17.2% · p75 32.0%top quartile
CapEx / revenue-2.5% medp25 -4.6% · p75 -1.4%
Debt / equity2.0%56.0% medp25 16.8% · p75 121.1%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 22:50 UTC#6a79e918
Market quoteclose USD 20.49 · shares 0.02B diluted
no public URL
2026-05-07 16:04 UTC#91b9a787
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 07:02 UTCJob: 0ec73df9